Clinical Trial Update: A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism [Phase 4]

View source ↗

Summary

Phase 4 study evaluating extended use of rhPTH(1-84) in hypoparathyroidism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• rhPTH(1-84) (recombinant human parathyroid hormone 1-84)

Snippet

Sponsor: Shire | Conditions: Chronic Hypoparathyroidism, Hypoparathyroidism | Phase 4 | Status: COMPLETED | Results posted: 2021-07-28